HRTX

Heron Therapeutics, Inc.

0.29

USD

0.00

+1.45%

Sep 25, 15:59 UTC -4

Closed

After-Market

0.29

0.00

-1.43%

Heron Therapeutics, Inc. Profile

About

Heron Therapeutics Inc. is a specialty pharmaceutical company. The company is developing products using its proprietary Biochronomer (TM) polymer-based drug delivery platform. Its product portfolio includes APF530, is being developed for the prevention of acute chemotherapy-induced nausea and vomiting. Heron Therapeutics Inc., formerly known as A.P. Pharma, Inc., is based in REDWOOD CITY CA.

Info & Links

CEO

Craig Collard

Headquarters

100 REGENCY FOREST DRIVE, SUITE 300
CARY, NC 27518, UNITED STATES

Auditor

WithumSmith+Brown, PC

Share holders

Employees

128

Heron Therapeutics, Inc. Statistics

Valuation Measures

Market Capitalization²

55.06M

Enterprise Value

176.99M

Enterprise Value/EBITDA(ttm)

-21.07

Price to Earnings Ratio(ttm)

Price to Sales(ttm)

0.36

Price to Book(mrq)

9.37

Price to Cash(ytd)

Profitability

Gross Margin(ttm)

70.01%

Operating Margin(ttm)

-16.60%

Profit Margin(ttm)

-22.75%

Return on Equity(ttm)

-293.02%

Return on Invested Capital(ttm)

-22.28%

Return on Assets(ttm)

-10.00%

Income Statement

Revenue(ttm)

151.18M

Revenue Per Share(ttm)

0.80

Gross Profit(ttm)

105.94M

EBITDA(ttm)³

-8.40M

Net Income Available to Common(ttm)

-34.05M

Diluted EPS(ttm)

-0.19

Share Statistics

Beta (5Y Monthly)

1.61

52-Week Change

-76.46%

S&P 500 52-Week Change

19.38%

S&P 500 Member

Stock Optionable

Yes

Total Shares Outstanding¹

189.85M

Dividend Yield

0.00%

Float⁴

178.27M

% Held by Insiders

6.10%

% Held by Institutions

80.01%

Balance Sheet

Total Cash(mrq)

42.66M

Total Cash Per Share(mrq)

0.22

Total Debt(mrq)

142.65M

Total Debt/Equity(mrq)

2065.00%

Current Ratio(mrq)

2.49%

Quick Ratio(mrq)

1.51%

Book Value Per Share(mrq)

0.04

Cash Flow

Operating Cash Flow Per Share(ytd)

-0.02

Free Cash Flow(ytd)

-4.28M

Table Key

mrq = Most Recent Quarter

ttm = Trailing Twelve Months

ytd = Year To Date

Footnotes

Data provided by Zacks Investment Research or calculated by FXEmpire. All numbers are rounded to the closest decimal.

1 Total Shares outstanding is taken from the most recently filed quarterly or annual report.
2 Market Cap is calculated using total shares outstanding and the most recent share price.
3 EBITDA is calculated using methodology that may differ from that used by a company in its reporting.
4 The float is a measure of the number of shares available for trading by the public. It's calculated by taking the number of issued and outstanding shares minus any restricted stock, which might not be publicly traded.